4284SOLXYZ

2999Home Position

3559p-ban.com

7640TOP CULTURE

6656inspec

2984Yamaichi Uniheim Real Estate

2767TSUBURAYA FIELDS HOLDINGS

3030HUB

7213LECIP HOLDINGS

4310Dream Incubator

6890Ferrotec Holdings

3277Sansei Landic

8925ARDEPRO

4012AXIS

7699OMNI-PLUS SYSTEM

3918PCI Holdings

8940INTELLEX

4985Earth Corporation

9340ASO INTERNATIONAL

6676MELCO HOLDINGS

9621CTI Engineering

3401Teijin

5805SWCC

7771Nihon Seimitsu

8918LAND

4304Estore

4293SEPTENI HOLDINGS

4572Carna Biosciences

6912KIKUSUI HOLDINGS

5011NICHIREKI

2154Open Up Group

3490Azplanning

2702Mcdonald's Holdings(Japan)

6840AKIBA Holdings

7810Crossfor

8179Royal Holdings

3173Cominix

4563AnGes

3196HOTLAND

5834SBI Leasing Services

7343Broad-Minded

3849NIPPON TECHNO LAB

3293AZUMA HOUSE

3916Digital Information Technologies

3294e'grand

3652Digital Media Professionals

3968Segue Group

6073ASANTE

4745Tokyo Individualized Educational Institute

1431Lib Work

3113UNIVA Oak Holdings

4674CRESCO

9377AGP

9857EIWA

3032GOLF DO

8119SANYEI CORPORATION

7092Fast Fitness Japan

7463ADVAN GROUP

6294OKADA AIYON

3097The Monogatari Corporation

4662Focus Systems

2488JTP

2735WATTS

2311EPCO

3395Saint Marc Holdings

9904Verite

4286CL Holdings

6835Allied Telesis HD

9517eREX

7112CUBE

3950THE PACK

4381BPLATS

3392DELICA FOODS HOLDINGS

8938GLOME Holdings

7637Hakudo

3457&Do Holdings

6157NS TOOL

6547GREENS

4891TMS

8737Akatsuki Corp

6625JALCO Holdings

6750ELECOM

4018Geolocation Technology

4171Global Information

4760ALPHA

9740CENTRAL SECURITY PATROLS

2492Infomart

3965Capital Asset Planning

6640I-PEX

3837Ad-Sol Nissin

2676TAKACHIHO KOHEKI

6837KYOSHA

5933ALINCO

2586FRUTA FRUTA

3753FLIGHT SOLUTIONS

9602TOHO

1430First-corporation

2384SBS Holdings

7376BCC

9787AEON DELIGHT

3435SANKO TECHNO

6867LEADER ELECTRONICS

6879IMAGICA GROUP

8934Sun Frontier Fudousan

8920TOSHO

2404TETSUJIN Holdings

6460SEGA SAMMY HOLDINGS

9622SPACE

1904TAISEI ONCHO

8051YAMAZEN

9960TOTECH

3839ODK Solutions

9997BELLUNA

9531TOKYO GAS

4379Photosynth

3387create restaurants holdings

4284SOLXYZ

2999Home Position

3559p-ban.com

7640TOP CULTURE

6656inspec

2984Yamaichi Uniheim Real Estate

2767TSUBURAYA FIELDS HOLDINGS

3030HUB

7213LECIP HOLDINGS

4310Dream Incubator

6890Ferrotec Holdings

3277Sansei Landic

8925ARDEPRO

4012AXIS

7699OMNI-PLUS SYSTEM

3918PCI Holdings

8940INTELLEX

4985Earth Corporation

9340ASO INTERNATIONAL

6676MELCO HOLDINGS

9621CTI Engineering

3401Teijin

5805SWCC

7771Nihon Seimitsu

8918LAND

4304Estore

4293SEPTENI HOLDINGS

4572Carna Biosciences

6912KIKUSUI HOLDINGS

5011NICHIREKI

2154Open Up Group

3490Azplanning

2702Mcdonald's Holdings(Japan)

6840AKIBA Holdings

7810Crossfor

8179Royal Holdings

3173Cominix

4563AnGes

3196HOTLAND

5834SBI Leasing Services

7343Broad-Minded

3849NIPPON TECHNO LAB

3293AZUMA HOUSE

3916Digital Information Technologies

3294e'grand

3652Digital Media Professionals

3968Segue Group

6073ASANTE

4745Tokyo Individualized Educational Institute

1431Lib Work

3113UNIVA Oak Holdings

4674CRESCO

9377AGP

9857EIWA

3032GOLF DO

8119SANYEI CORPORATION

7092Fast Fitness Japan

7463ADVAN GROUP

6294OKADA AIYON

3097The Monogatari Corporation

4662Focus Systems

2488JTP

2735WATTS

2311EPCO

3395Saint Marc Holdings

9904Verite

4286CL Holdings

6835Allied Telesis HD

9517eREX

7112CUBE

3950THE PACK

4381BPLATS

3392DELICA FOODS HOLDINGS

8938GLOME Holdings

7637Hakudo

3457&Do Holdings

6157NS TOOL

6547GREENS

4891TMS

8737Akatsuki Corp

6625JALCO Holdings

6750ELECOM

4018Geolocation Technology

4171Global Information

4760ALPHA

9740CENTRAL SECURITY PATROLS

2492Infomart

3965Capital Asset Planning

6640I-PEX

3837Ad-Sol Nissin

2676TAKACHIHO KOHEKI

6837KYOSHA

5933ALINCO

2586FRUTA FRUTA

3753FLIGHT SOLUTIONS

9602TOHO

1430First-corporation

2384SBS Holdings

7376BCC

9787AEON DELIGHT

3435SANKO TECHNO

6867LEADER ELECTRONICS

6879IMAGICA GROUP

8934Sun Frontier Fudousan

8920TOSHO

2404TETSUJIN Holdings

6460SEGA SAMMY HOLDINGS

9622SPACE

1904TAISEI ONCHO

8051YAMAZEN

9960TOTECH

3839ODK Solutions

9997BELLUNA

9531TOKYO GAS

4379Photosynth

3387create restaurants holdings

What's New
New Analyst Reports
Information

What's New

  • 02/23/2024NEW
  • ARDEPRO(8925)
  • Notice Concerning Designation of ARDEPRO Shares as Securities Under Supervision (Examination)
  • (Disclosure Change) Notice Concerning Abandonment of Formulation and Publication of Improvement Plans
  • 02/22/2024
  • Earth Corporation(4985)
  • [Delayed]Earnings Briefing Materials for the Fiscal Year Ended December 2023 and the New Mid-term Business Plan
  • CTI Engineering(9621)
  • Notice of Changes in Directors and Executive Officers
  • Notice of Policy to Hold an Adjournment of the 61st Annual General Meeting of Shareholders and Appropriation of Surplus
  • Status of Internal Investigation into Inappropriate Cost Management
  • AnGes(4563)
  • Consolidated Financial Report for the Fiscal Year 2023(correction)
  • The Monogatari Corporation(3097)
  • Reference material for briefing the financial results for the second quarter of the FY ending June 2024
  • ALINCO(5933)
  • [Delayed]Supplementary Materials for the Third Quarter of the Fiscal Year Ending March 20, 2024
  • Open Up Group(2154)
  • Notice of Monthly Disclosure of Utilization Rates and January of Domestic Engineers and Workers as of the end of January 2024
  • TOTECH(9960)
  • Supplementary Material for Q3 FY3/24
  • Sansei Landic(3277)
  • [Delayed]Announcement of change in dividend policy (Implementation of interim dividend)
  • 02/21/2024
  • ELECOM(6750)
  • Notice regarding a Change in Representative Director and President
  • 02/20/2024
  • Fast Fitness Japan(7092)
  • Notice Concerning Conclusion of Master Franchise Agreement
  • &Do Holdings(3457)
  • Announcement of Alliance with Juroku Bank concerning House-Leaseback NeedsMatching Agreements
  • Shared Research Inc. short report on earnings results for the Second Quarter of FY06/2024 has been issued
  • Earnings Results for the Second Quarter of the Fiscal Year Ending June 2024
  • Announcement of Revisions to Consolidated Earnings Forecast for the First Half of the Fiscal Year Ending June 30, 2024
  • Announcement Regarding the Signing of a Sustainability-Linked Loan Agreement with Kiyo Bank
  • YAMAZEN(8051)
  • Notice Regarding Change of Directors
  • TMS(4891)
  • JIXING Announced the First Subject Dosing of JX09 Phase I Clinical Trial
  • 02/19/2024
  • YAMAZEN(8051)
  • FY3/24 (Q3) Supplementary Materials for Financial Results
  • Ferrotec Holdings(6890)
  • Notice of the Revision to the Full-year Consolidated Business Forecasts
  • Notice of the Selection of Our Stock as a Nikkei Semiconductor Share Index Constituent
  • SBS Holdings(2384)
  • Q&A Sessions at the FY12/23 Financial Results Briefing
  • 02/16/2024
  • SBS Holdings(2384)
  • Analyst Report(Shared Research) : Released full-year FY12/23 results
  • Dream Incubator(4310)
  • Q3 FY03/2024 Supplementary Materials for Consolidated Financial Results
  • 02/15/2024
  • Photosynth(4379)
  • FY2023 4th Quarter Results Presentation - Q&A (Summary)
  • Ferrotec Holdings(6890)
  • Analyst Report(Shared Research) : Full-year earnings forecast revised
  • MELCO HOLDINGS(6676)
  • {Delayed]Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2023
  • Ferrotec Holdings(6890)
  • Analyst Report(Shared Research) : Released Q3 FY03/24 results
  • Open Up Group(2154)
  • FY24 Q2 Financial Results
  • EPCO(2311)
  • [Delayed]Summary of Consolidated Financial Results for the Year Ended December31,2023(Based on Japanese GAAP)
  • SEPTENI HOLDINGS(4293)
  • Notice of Improper Use of Expenses by Representative Director and Measures to Prevent Recurrence
  • AnGes(4563)
  • FY2023 Financial Results Materials
  • ELECOM(6750)
  • DelayedConsolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2024
  • CUBE(7112)
  • Non-consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Under Japanese GAAP)
  • Infomart(2492)
  • Analyst Report(Shared Research) : Released full-year FY12/23 results
  • SWCC(5805)
  • Supplementary Material for the Third Quarter of the Fiscal Year Ending March 2024
  • 02/14/2024
  • Sansei Landic(3277)
  • Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Under Japanese GAAP)
  • OMNI-PLUS SYSTEM(7699)
  • OPS announces Toll Compounding Agreement with BASF
  • Infomart(2492)
  • FY12/23 Full-Year Financial Results
  • BPLATS(4381)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • BCC(7376)
  • Non-consolidated Financial Results for the Three Months Ended December 31, 2023 (Under Japanese GAAP)
  • Infomart(2492)
  • Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Under Japanese GAAP)
  • Ferrotec Holdings(6890)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • Akatsuki Corp(8737)
  • Summary of Business Results for the Third Quarter Ended December 31, 2023 [Japan GAAP] (Consolidated)
  • GLOME Holdings(8938)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • Digital Information Technologies(3916)
  • Consolidated Financial Results for the Six Months Ended December 31, 2023 (Under Japanese GAAP)
  • AZUMA HOUSE(3293)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • HOTLAND(3196)
  • Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Under Japanese GAAP)
  • OMNI-PLUS SYSTEM(7699)
  • Consolidated Financial Statements for the Third Quarter of the Financial Year Ending March 31, 2024.
  • GREENS(6547)
  • DelayedSummary of Consolidated Financial Results for the Six Months Ended December 31, 2023
  • Fast Fitness Japan(7092)
  • Summary of Consolidated Financial Results for the First Nine Months ended December 31, 2023
  • CL Holdings(4286)
  • Summary of Financial Results 2023
  • OMNI-PLUS SYSTEM(7699)
  • Notice Regarding Conclusion of Joint Research and Development Agreement with Hinode Resin
  • Notice of Revision of Full-year Earnings Forecast
  • SBS Holdings(2384)
  • Notice of Executive Personnel Changes
  • Notice of Executive Personnel Changes at Affiliated Companies
  • Summary of Financial Results 2023
  • TSUBURAYA FIELDS HOLDINGS(2767)
  • Fact Book (Supplementary Financial Document for the third quarter of fiscal year ending March 31, 2024)
  • Earth Corporation(4985)
  • Analyst Report(Shared Research) : Released full-year FY12/23 results
  • SEGA SAMMY HOLDINGS(6460)
  • (Progress of Disclosure Matters) Notice of Approval of Special General Meeting of Shareholders regarding the Acquisition of GAN Limited
  • 02/13/2024
  • HOTLAND(3196)
  • Monthly Sales Report (January)
  • Royal Holdings(8179)
  • January 2024 Monthly Sales Report (Same-store sales)
  • Segue Group(3968)
  • Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Under Japanese GAAP)
  • MELCO HOLDINGS(6676)
  • Analyst Report (Shared Research) : Released Q3 FY03/24 results
  • Hakudo(7637)
  • Analyst Report(Shared Research) : Revisions to earnings targets, a change of dividend policy, and a revision to the year-end dividend forecast (increased)
  • Analyst Report(Shared Research) : Released Q3 FY03/24 results
  • AKIBA Holdings(6840)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • p-ban.com(3559)
  • Non-consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • Broad-Minded(7343)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • Nihon Seimitsu(7771)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • &Do Holdings(3457)
  • Summary of Business Results for the Second Quarter Ended December 31, 2023 [Japan GAAP] (Consolidated)
  • Estore(4304)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • YAMAZEN(8051)
  • Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Based on Japanese GAAP)
  • Photosynth(4379)
  • FY2023 4Q & Full Year Results
  • Consolidated Financial Results for the Year Ended December 31, 2023 [Japanese GAAP]
  • 2024 Feb. Business Plan & Growth Strategy Presentation
  • SPACE(9622)
  • Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Under Japanese GAAP)
  • Earth Corporation(4985)
  • Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 [JGAAP]
  • Notice Regarding Dividends of Surplus
  • I-PEX(6640)
  • Presentation Materials for the Fiscal Year Ending December 31, 2023
  • TOHO(9602)
  • January 2024 Preliminary Report on Monthly Box Office Revenue (Distributed Dept./Movie Theater Chain)
  • TSUBURAYA FIELDS HOLDINGS(2767)
  • Analyst Report(Shared Research) : Upward revision of dividend forecast
  • Analyst Report(Shared Research) : Released Q3 FY03/24 results
  • Carna Biosciences(4572)
  • Analyst Report(Shared Research) : Released full-year FY12/23 results
  • Yamaichi Uniheim Real Estate(2984)
  • [Delayed] Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • DELICA FOODS HOLDINGS(3392)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • HUB(3030)
  • January 2024 Monthly Report
  • 02/09/2024
  • TSUBURAYA FIELDS HOLDINGS(2767)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023
  • Notice of revision of dividend forecast (dividend increase)
  • I-PEX(6640)
  • Fact Sheet 2023
  • JALCO Holdings(6625)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • CRESCO(4674)
  • [Delayed] Notice Concerning Changes in Dividend Policy
  • Capital Asset Planning(3965)
  • Consolidated Financial Results for the Three Months Ended December 31, 2023 (Under Japanese GAAP)
  • Lib Work(1431)
  • Consolidated Financial Results for the Six Months Ended December 31, 2023 (Under Japanese GAAP)
  • SOLXYZ(4284)
  • Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Under Japanese GAAP)
  • Sun Frontier Fudousan(8934)
  • Analyst Report (Shared Research) : Revision to FY03/24 consolidated earnings forecast
  • Analyst Report (Shared Research) : Released Q3 FY03/24 results
  • eREX(9517)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • AnGes(4563)
  • Consolidated Financial Report for the Fiscal Year 2023
  • Global Information(4171)
  • Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Under Japanese GAAP)
  • Carna Biosciences(4572)
  • Corporate Presentation Feb. 2024
  • FY2023 Presentation
  • Consolidated Financial Results for the Year Ended December 31, 2023
  • CTI Engineering(9621)
  • Notice of Postponement of Announcement of Financial Results of FY2023 and Establishment of an Internal Investigation Committee
  • I-PEX(6640)
  • Financial Results for the Fiscal Year Ended December 31, 2023 [Japan GAAP] (Consolidated)
  • LECIP HOLDINGS(7213)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • TAISEI ONCHO(1904)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • NS TOOL(6157)
  • [Delayed]Summary of Business Results for the Third Quarter Ended December 31, 2023 [Japan GAAP] (Consolidated)
  • The Monogatari Corporation(3097)
  • Corporate Governance Report
  • Focus Systems(4662)
  • Summary of Financial Results for the third quarter 2024
  • THE PACK(3950)
  • Summary of Financial Results 2023
  • Open Up Group(2154)
  • Regarding the Revision of Performance Forecasts Due to Changes in Consolidated Subsidiaries
  • Consolidated Financial Results for the Six Months Ended December 31, 2023 (Under IFRS)
  • The Monogatari Corporation(3097)
  • Notice Regarding January 2024 Preliminary Monthly YoY Change in Sales and Number of Restaurants
  • Hakudo(7637)
  • Notice Concerning Revision of Dividend Forecast and Revision of Year-End Dividend Forecast (Dividend Increase)
  • Notice Concerning Revisions to Financial Results Forecasts
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • The Monogatari Corporation(3097)
  • Summary of Financial Results for the second quarter 2024
  • NICHIREKI(5011)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 [Japanese GAAP]
  • OKADA AIYON(6294)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • Verite(9904)
  • January 2024 Flash Report vs. LY
  • SEGA SAMMY HOLDINGS(6460)
  • Data Appendix (FY2024/3 Q3)
  • Notice of Revision of Operating Results Forecast
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Japanese GAAP)
  • Q3 for the Fiscal Year Ending March 2024 Results Presentation
  • SWCC(5805)
  • Notice of Revision to Business Forecasts (Upward Revision of Profits) and Dividend Forecasts (Increase) for the Fiscal Year Ending March 31, 2024
  • 02/08/2024
  • LEADER ELECTRONICS(6867)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • SANKO TECHNO(3435)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • AXIS(4012)
  • Non-consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Under Japanese GAAP)
  • CUBE(7112)
  • [Delayed] [FY12/24] Preliminary Monthly Sales Report of Directly Managed Stores for January 2024
  • SEPTENI HOLDINGS(4293)
  • (Progress of Disclosed Matter) Notice of Changes in Consolidated Subsidiary (Share Transfer) and Recognition of Gain on Sale
  • Sun Frontier Fudousan(8934)
  • Notice of Revision to Financial Results Forecast for FY2024/3 and Revision to Cash Dividend Forecast (Increase and Commemorative dividend)
  • Financial Results for the Third Quarter of Fiscal Year Ending March 31,2024
  • Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024
  • SEPTENI HOLDINGS(4293)
  • Summary of Consolidated Financial Statement for the Fiscal Year Ended December 31, 2023 [IFRS]
  • Notice of Revision of Year-End Dividend Forecast (Dividend Increase)
  • Teijin(3401)
  • Notice Regarding the Recording of Insurance Income
  • Notice Regarding Recording of Non-operating Income (Equity in Earnings of Affiliates) due to Partial Resolution of Litigation
  • Notice Regarding the Revision of Financial Forecasts
  • Flash Report - Results of FY2023 3Q & Outlook for FY2023 -
  • Consolidated Financial Statements Summary (For the nine months ended December 31, 2023)
  • Mcdonald's Holdings(Japan)(2702)
  • 2023 Full Year Earnings Release
  • Notice of Distribution of Dividends from Surplus (Dividend Increase)
  • Consolidated Financial Results for the Year ended December 31, 2023
  • Consolidated Financial Results for the Fiscal Year Ended December 31, 2023, and FY2024 Earnings Forecast
  • WATTS(2735)
  • Notice Regarding January 2024 Monthly YoY Change in Sales and Number of Shops
  • 02/07/2024
  • Carna Biosciences(4572)
  • Carna Biosciences and Carterra Jointly Present at SLAS2024
  • Ad-Sol Nissin(3837)
  • Notice of Revisions to Full-year Operating Results Forecast and Year-end Dividend Forecast (Dividend increase) for FY24/3
  • ARDEPRO(8925)
  • (Disclosure Update) Notice Concerning Conclusion of a Sale Contract and Settlement of Sale for Real Estate for Sale
  • PCI Holdings(3918)
  • Financial Results for the Three Months Ended December 31,2023
  • [Summary]Consolidated Financial Results for the Three Months Ended December 31,2023
  • Ad-Sol Nissin(3837)
  • Financial results for Q3 FY'24/3
  • Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024 (Japanese GAAP, Consolidated)
  • 02/06/2024
  • NICHIREKI(5011)
  • [Delayed]Notice Concerning Status of Acquisition of Treasury Stock
  • IMAGICA GROUP(6879)
  • Notice Regarding Management Change Representative Director
  • Notice Regarding Management Change Executive Officers and President of Subsidiary
  • Saint Marc Holdings(3395)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • CRESCO(4674)
  • [Delayed] Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Based on Japanese GAAP)
  • TAKACHIHO KOHEKI(2676)
  • [Summary] Consolidated Financial Results for the Nine Months Ended December 31, 2023
  • ARDEPRO(8925)
  • Notice Regarding Changes (Downward Revision) to the Consolidated Business Results Forecast for FY2024
  • Notice Regarding Revision of Dividend Forecast (No Distribution)
  • IMAGICA GROUP(6879)
  • Consolidated Financial Highlights for the Third Quarter of the Fiscal Year Ending March 31, 2024 Supplemental Materials
  • Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024 (J-GAAP)
  • Mcdonald's Holdings(Japan)(2702)
  • Monthly IR News
  • ASANTE(6073)
  • January Monthly Sales Report for FY Ending March 2024
  • Financial Results for the Third Quarter Ended December 31, 2023 - Supplementary Material
  • [Summary] Summary of Business Results for the Third Quarter Ended December 31, 2023
  • 02/05/2024
  • CRESCO(4674)
  • [Delayed] Notice Concerning Agreement on Reorganization Between the Company and Consolidated Subsidiaries
  • ALINCO(5933)
  • Analyst Report(Shared Research): Released Q3 FY03/24 results
  • 02/02/2024
  • TOP CULTURE(7640)
  • FY10/2024 Preliminary sales figures (January)
  • SANYEI CORPORATION(8119)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • SWCC(5805)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • SEGA SAMMY HOLDINGS(6460)
  • Notice regarding Like a Dragon: Infinite Wealth Reaches One Million Units Shipped in First Week; Fastest-Selling Title in the Series
  • ALINCO(5933)
  • Consolidated Financial Results for the Nine Months Ended December 20, 2023 (Under Japanese GAAP)
  • Dream Incubator(4310)
  • Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Based on Japanese GAAP)
  • Analyst Report(Shared Research) : Released Q3 FY03/24 results
  • TOTECH(9960)
  • Notice of Revisions to Consolidated Business Forecast and Dividend Forecast
  • Notice of Stock Split and Partial Change to Articles of Incorporation
  • 02/01/2024
  • ARDEPRO(8925)
  • (Disclosure Update) Notice Concerning Completion of Conclusion of Sale Contract for Real Estate for Sale
  • MELCO HOLDINGS(6676)
  • Notice Concerning Status of Purchase of Treasury Shares
  • Cominix(3173)
  • Consolidated Financial Results for the Nine Months Ended December 31 , 2023 (Under Japanese GAAP)
  • NS TOOL(6157)
  • Analyst Report (Shared Research) : Released Q3 FY03/24 results
  • ELECOM(6750)
  • Notice Regarding the Status of Acquisition of Treasury Sharets
  • 01/31/2024
  • NIPPON TECHNO LAB(3849)
  • Non-consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • TOTECH(9960)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • Sun Frontier Fudousan(8934)
  • Analyst Report(Shared Research): Opening 12th location, Ikebukuro branch
  • ODK Solutions(3839)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • e'grand(3294)
  • Non-consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • NS TOOL(6157)
  • Summary of Business Results for the Third Quarter Ended December 31, 2023 [Japan GAAP] (Consolidated)
  • YAMAZEN(8051)
  • YAMAZEN 2023 Integrated Report
  • 01/30/2024
  • Earth Corporation(4985)
  • Analyst Report(Shared Research) : Revised full-year FY12/23 forecast, recording of extraordinary loss
  • SBI Leasing Services(5834)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • AGP(9377)
  • Consolidated Financial Results for the Nine Months Ended December 31, 2023 (Under Japanese GAAP)
  • 01/29/2024
  • AnGes(4563)
  • Notice of Business Restructuring at Consolidated Subsidiary
  • create restaurants holdings(3387)
  • Notice of the Filing of Correction Reports on Previous-Year Securities Reports, etc. and the Correction of Previous-Year Summary of Business Results
  • Earth Corporation(4985)
  • Notice Concerning Revisions of the forecast of Results for FY2023 and the Recording of an Extraordinary Loss [JGAAP]
  • TOHO(9602)
  • DelayedFinancial Results Presentation Third Quarter of the Fiscal Year Ending February 2024
  • 01/26/2024
  • create restaurants holdings(3387)
  • Notice of Conclusion of Comprehensive Business Alliance with JA ZEN-NOH
  • AEON DELIGHT(9787)
  • Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q3 FY02/24 [Report Update]
  • ARDEPRO(8925)
  • (Cancellation of Disclosed Matter) Notice Concerning Cancellation of Sales Contract for Real Estate for Sale
  • Open Up Group(2154)
  • Notice of Monthly Disclosure of Utilization Rates and Number of Domestic Engineers and Workers as of the end of December 2023
  • SBS Holdings(2384)
  • (Progress of the Disclosed Item) Notice of Transfer of Trust Beneficiary Rights of Our Consolidated Subsidiaries
  • Information

    Information

       1/19   What's new: Fast Fitness Japan (7092)


       12/20   What's new: SPACE (9622)


       10/13   What's new: Sun Frontier Fudousan (8934)



    Newly Added Company

    Date1/19
    Fast Fitness Japan7092Prime

    Date12/20
    SPACE9622Prime

    Latest Video & Presentations

    Latest Video&Slides

    Company news
    provided by Timely Disclosure Network

    News Release

    Stock Code or Name:

    4503   Astellas Pharma Inc.

    02/21/2024 08:30 Presentation Material for Sustainability Meeting
    02/05/2024 15:00 Financial Results (Q3/FY2023)
    02/05/2024 15:00 Supplementary Documents (Q3/FY2023)
    02/05/2024 15:00 Presentation Material for Information Meeting (Q3/FY2023)
    01/31/2024 11:00 Astellas Submits Supplemental New Drug Application in Japan for PADCEV with KEYTRUDA for First Line Treatment of Advanced Bladder Cancer
    01/29/2024 08:30 EMA Validates Type II Variation Application for PADCEV with KEYTRUDA for First-Line Treatment of Advanced Bladder Cancer
    01/09/2024 08:30 Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.
    12/26/2023 11:00 Corporate Governance Report
    12/22/2023 08:30 Astellas Completes Acquisition of Propella Therapeutics
    12/18/2023 08:30 PADCEV with KEYTRUDA Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
    12/01/2023 08:30 FDA Grants Priority Review for sBLA of PADCEV with KEYTRUDA for First-Line Treatment of Advanced Bladder Cancer
    11/17/2023 15:00 Pfizer and Astellas' XTANDI Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
    11/16/2023 08:30 Astellas to Acquire Propella Therapeutics
    11/01/2023 15:00 Financial Results (Q2/FY2023)
    11/01/2023 15:00 Supplementary Documents (Q2/FY2023)
    11/01/2023 15:00 Presentation Material for Information Meeting (Q2/FY2023)
    10/16/2023 08:30 Astellas Receives Positive CHMP Opinion for VEOZA(fezolinetant)
    09/22/2023 18:00 PADCEV and KEYTRUDA Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer
    09/19/2023 08:00 Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY (avacincaptad pegol intravitreal solution) for Geographic Atroph
    09/13/2023 08:30 European Medicines Agency Validates Type II Variation for Astellas' XTANDI for Treatment of Non Metastatic Hormone-Sensitive Prostate Cancer
    08/25/2023 15:00 Notice Regarding Issuance of Unsecured Bonds
    08/24/2023 08:30 FDA Grants Priority Review for XTANDI in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
    08/07/2023 08:00 Iveric Bio Receives U.S. FDA Approval for IZERVAY (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy
    08/01/2023 15:00 Transforming Astellas Japan Commercial business to deliver growth for the future
    08/01/2023 15:00 Presentation Material for Information Meeting (Q1/FY2023)
    08/01/2023 15:00 Supplementary Documents (Q1/FY2023)
    08/01/2023 15:00 Financial Results (Q1/FY2023)
    07/12/2023 08:00 Astellas Completes Acquisition of Iveric Bio
    07/06/2023 15:00 Astellas Announces U.S. FDA Grants Priority Review for Zolbetuximab Biologics Licese Application
    06/12/2023 08:30 Astellas Confirms Unfavorable District Court Decision in Myrbetriq U.S. Patent Trial
    06/09/2023 13:00 Astellas Submits New Drug Apprication for Zolbetuximab in Japan
    05/30/2023 08:00 Notice of Convocation of the 18th Term Annual Shareholders Meeting
    05/17/2023 16:05 Notice Regarding Continuation of the Performance-linked Stock Compensation Scheme for the Domestic and Global Astellas Group Executives
    05/17/2023 16:00 Notice Regarding Continuation of the Performance-linked Stock Compensation Scheme
    05/11/2023 08:30 Astellas Confirms Final Federal Circuit Decision in LEXISCAN 0.4 mg/mL U.S. Patent Appeal
    05/01/2023 08:00 Astellas Enters into Definitive Agreement to Acquire Iveric Bio
    05/01/2023 08:00 Astellas Enters into Definitive Agreement to Acquire Iveric Bio
    04/27/2023 15:00 Changes of Representative Director and Directors
    04/27/2023 15:00 Presentation Material for Information Meeting (FY2022)
    04/27/2023 15:00 Supplementary Documents (FY2022)
    04/27/2023 15:00 Financial Results (FY2022)
    04/11/2023 15:00 Notice Regarding Impairment Loss and Revision of Financial Forecasts for FY2022
    04/04/2023 08:00 FDA Grants Accelerated Approval for PADCEV with KEYTRUDA for First-Line Treatment of Locally Advanced or M
    03/17/2023 08:30 Phase 3 Study Shows XTANDI (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer
    03/16/2023 15:30 Astellas Announces Completion of Acquisition of Own Shares, and Cancellation of Treasury Stock
    03/14/2023 08:30 Astellas Announces Phase 3 China ARCHES Study of XTANDI Meets Primary Endpoint
    03/10/2023 08:30 Astellas and Seagen Announce China's NMPA Accepts BLA for Enfortumab Vedotin in Certain Patients with Locally Advanced or Metastatic Urothelial Cancer
    03/09/2023 15:00 Astellas and BMT CTN Announce Topline Results from Phase 3 MORPHO Trial of Gilteritinib
    03/01/2023 13:00 Astellas Announces Status of Acquisition of Own Shares